CCC(=O)N1N/C(=C2/C(=O)NC(=O)N(CCc3ccccc3)C2=O)CC1c1ccc(OC)c(OC)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?